Finance

Beta
Lists
003000:KRX
Bukwang Pharm Co Ltd
â‚©4,285.00
+0.94%
(+40.00) 1D
Jun 11, 2:55:44 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003000...
Open
â‚©4,190
High
â‚©4,300
Low
â‚©4,085
Mkt. cap
422.78B
Avg. vol.
1.05M
Volume
269.84K
Dividend
2.92%
Quarterly dividend
â‚©31
Ex-dividend date
Dec 29, 2025
P/E ratio
26.11
52-wk high
â‚©9,890
52-wk low
â‚©3,200
EPS
â‚©164
Shares outstanding
98.66M
No. of employees
615
Open
â‚©4,190
High
â‚©4,300
Low
â‚©4,085
Mkt. cap
422.78B
Avg. vol.
1.05M
Volume
269.84K
Dividend
2.92%
Quarterly dividend
â‚©31
Ex-dividend date
Dec 29, 2025
P/E ratio
26.11
52-wk high
â‚©9,890
52-wk low
â‚©3,200
EPS
â‚©164
Shares outstanding
98.66M
No. of employees
615
News stories
From sources across the web
About Bukwang Pharm Co Ltd
CEOKim Sang-hun | Hui Won Yoo
Employees615
Founded1960
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
42.58B
47.81B
62.51B
47.78B
Cost of goods sold
23.88B
28.36B
29.86B
28.83B
Cost of revenue
23.88B
28.36B
29.86B
28.83B
Research and development expenses
4.40B
4.24B
6.31B
4.56B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.42B
14.23B
17.02B
12.47B
Operating expense
16.68B
18.47B
24.50B
17.84B
Total operating expenses
40.57B
46.84B
54.36B
46.67B
Operating income
2.01B
979.05M
8.16B
1.10B
Other non operating income
486.68M
244.96M
3.01B
981.71M
EBT including unusual items
2.50B
1.22B
2.99B
2.09B
EBT excluding unusual items
2.50B
1.22B
11.56B
2.09B
Income tax expense
-3.89B
-272.07M
-1.67B
924.48M
Effective tax rate
-155.85%
-22.24%
-55.87%
44.32%
Other operating expenses
385.01M
-
628.87M
274.74M
Net income
6.43B
1.53B
4.67B
1.18B
Net profit margin
15.09%
3.20%
7.47%
2.46%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4.71B
-
Interest expense
-
-
-3.90B
-
Net interest expenses
-
-
815.55M
-
Depreciation and amortization charges
335.47M
-
350.64M
352.10M
EBITDA
3.38B
2.40B
9.70B
2.48B
Gain or loss from assets sale
-
-299.00K
-12.46M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more